Previous Page  8 / 16 Next Page
Information
Show Menu
Previous Page 8 / 16 Next Page
Page Background

allied

academies

Page 29

Microbiology: Current Research | Volume 3

May 20-21, 2019 | Vienna, Austria

Medical Microbiology

4

th

International Conference on

Notes:

Predictive value of microRNAs for decreasing CD4 T cell count among HIV-1-

infected patients who spontaneously control viral replication (HIV controllers)

Alejandro Vallejo

Ramón y Cajal University Hospital, Spain

Background:

A small group of HIV-1-infected individuals

(5-15%) control disease progression for several years in the

absence of any antiretroviral therapy. Among this group, elite

controllers spontaneously control HIV-1 replication (below 50

HIV-1 RNA copies/ml); nevertheless, they are still susceptible

to have several aspects of the immune response deregulated,

especially elevated immune activation and inflammation.

Homeostatic factors contribute to maintain a stable pool of

T cells in this situation where T cell apoptosis is enhanced.

This situation promotes the release of micro vesicles, such

as exosomes that are released by the cells and are present

in blood, urine and saliva. This content includes miRNAs,

small non-coding RNA capable of recognizing specific mRNA

and inhibiting its translation into proteins. These molecules

may thus promote hematopoietic stem cells and regulate

the immune system and inflammatory processes that

could influence the homeostasis cell equilibrium. HIV could

interfere with the exosomal pathway. The direct influence of

exosomal miRNAs on the cells of the immune system during

HIV infection is a topic that is still poorly understood. Since

exosomes can modulate immune responses and may affect

HIV pathogenesis, we conducted this cross-sectional study of

quantification of selected miRNAs in HIV elite controllers. We

also investigated the association of plasma-derived exosome

miRNA levels with both soluble cytokine levels and cellular

immune activation.

Methods:

Two groups of elite controllers were analysed,

i.e., those that during the follow up had stable or increasing

CD4 T cell count (SEC, N=21), and those who had significant

decline of CD4 T cell count (DEC, N=11). Plasma-derived

exosomes were used to determine the expression of miRs

and determine their association to soluble cytokine markers

and cellular immune activation.

Results:

Plasma exosome-derived miR-16 and miR-21 are

downregulated in DEC group, while miR-221 was upregulated

compared to SEC group. Only miR-21 was independently

associatedwith CD4 T cell decline in elite controllers (p=0.049;

odds ratio 0.369, IC95 [0.137-0.994]). On the other hand,

negative correlation between plasma exosome-derived miR-

21 and MCP-1 was found (p=0.020). No correlation between

expression of miRs and cellular immune activation markers

was found.

Conclusion:

Exosome-derived miR-21 might be used as a

valuable prognosis soluble biomarker to define HIV-1 elite

controllers who will have significant decay in their CD4 T cell

counts.

e

:

alejandro.vallejo@salud.madrid.org

Microbiol Curr Res, Volume 3

DOI: 10.4066/2591-8036-C1-006